On the contrary, the tumor-promoting (oncogenic) effects of SYVN1 have been revealed in colon cancer (78), lung cancer (79, 80), and hepatocellular carcinoma (81, 82). This evidence concerns the gene SYVN1 and hepatocellular carcinoma.